Clinical and experimental pharmacology & physiology · 2015
Protective effects of diltiazem against vascular endothelial cell injury induced by angiotensin-II and hypoxia.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Minggao, Li Jing, Meng Guo, Liu Xin
Аннотация
To provide pharmacological data for future clinical studies, this study investigated the protective effects of diltiazem on vascular endothelial cell (VEC) injury induced by angiotensin-II (AngII), hypoxia, and a combination of both treatments. The concentration of intracellular free calcium and the mitochondrial membrane potential in VEC were assessed as indicators of cell injury. An in vivo hypoxic animal model was used to test the protective effect of diltiazem on vascular endothelial tissues. Our study showed that AngII and hypoxia decreased the mitochondrial membrane potential in VEC, which was significantly inhibited by diltiazem. Diltiazem protected against VEC injury induced by the increased concentration of intracellular free calcium, which was associated with AngII and hypoxia. Diltiazem reduced the apoptosis of rat VEC under a sustained hypoxic condition. In addition, it reduced AngII and endothelin I levels in rat vascular endothelial tissues. Our study confirmed that AngII and hypoxia induced VEC injury by regulating the levels of mitochondrial membrane potential and intracellular free calcium. Diltiazem, a calcium channel blocker, protected VEC from AngII- and hypoxia-induced injury.
Предметные рубрики MeSH
Angiotensin IIAnimalsApoptosisCalcitonin Gene-Related PeptideCalcium Channel BlockersCalcium SignalingCells, CulturedCytoprotectionDiltiazemDisease Models, AnimalEndothelial CellsEndothelin-1HumansHypoxiaMaleMembrane Potential, MitochondrialMitochondriaNitric OxideNitric Oxide Synthase Type IIIRats, WistarVascular Diseases